Interestingly, unlike hEx3-Db, the HL-type hEx16-Db (hEx16-HL) inhibited cancer growth most effectively, although similar cross-linking abilities were predicted and observed for both hEx16-HL and the corresponding LH type (hEx16-LH). The gene discussed is PLOD1; the disease is cancer.